TB-500 (Thymosin Beta-4 fragment)
TB-500 is a short synthetic piece of the natural protein thymosin beta-4. It is studied for tissue recovery after sports injuries, but it has no human studies of its own — all data were obtained for the full protein.
Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln — a synthetic fragment of the 17-23 region of Tβ4. ~888 Da. ≠ Full-length Tβ4 (43 aa).
A synthetic Tβ4 fragment designed to reproduce its actin-binding activity. Popular in sports communities. No clinical studies of its own — all data relate to full-length Tβ4 (Phase I + Phase II RCTs). Practice: tissue regeneration after sports injuries.
LKKTETQ motif → G-actin binding → ↑cell migration to the injury. Partial angiogenesis and anti-inflammatory action (only via LKKTETQ, without the other Tβ4 domains).
Studies used 2-5 mg SC 2-3 times/week for a course of 4-6 weeks.
Level D Cells and reviews. Only cell studies (in vitro), theory, or reviews. The earliest stage. no clinical data of its own
Research peptides are laboratory reagents (Research Use Only). They are not medicines and are not intended for use in humans or animals.